Status:

UNKNOWN

Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea

Lead Sponsor:

Associacao Fundo de Incentivo a Psicofarmcologia

Conditions:

Obstructive Sleep Apnea

Obesity

Eligibility:

All Genders

30-65 years

Brief Summary

The purpose of this study is: 1. To determine the frequency of cardiovascular diseases in patients with OSA, obese, overweight, and lean (BMI\<25) 2. To analyze the CPAP treatment over the clinical e...

Detailed Description

Obstructive Sleep Apnea (OSA) is a condition with important cardiovascular repercussions. However, the association between OSA, cardiovascular diseases, and obesity has not been totally clarified. We ...

Eligibility Criteria

Inclusion

  • Men and women with OSA (apnea-hypopnea index higher than 5 events/hour)

Exclusion

  • Body mass index higher than 40

Key Trial Info

Start Date :

April 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2012

Estimated Enrollment :

2000 Patients enrolled

Trial Details

Trial ID

NCT00768625

Start Date

April 1 2005

End Date

December 1 2012

Last Update

October 8 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Instituto do Sono/AFIP

São Paulo, São Paulo, Brazil, 04516001